Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Keulers (LEEUWARDEN, Netherlands), A. Van Der Meer (LEEUWARDEN, Netherlands), A. Ten Brinke (LEEUWARDEN, Netherlands). Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.. 2254

Member's Comments

No comment yet.

Related content which might interest you: The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005 Eosinophilic inflammation in sputum of poorly controlled asthmatics Source: Eur Respir J 2002; 20: 1370-1377 Year: 2002 FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD Source: Eur Respir J 2016; 47:1562-1564 Year: 2016 Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005 Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Mechanisms of noneosinophilic asthma Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Inflammatory cell counts in induced sputum from non-allergic asthmatics and COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Sputum eosinophils and bronchial hyperreactivity in patients with chronic cough Source: Eur Respir J 2005; 26: Suppl. 49, 479s Year: 2005 Sputum neutrophilic markers in asthma of varying severity and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 Subjects in a population study with high levels of FENO have associated eosinophil airway inflammation in BAL Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004 Disconnect between sputum neutrophils and other measures of airway inflammation in asthma Source: Eur Respir J 2014; 43: 627-629 Year: 2013 Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004 Dissosiation between eosinophils in sputum and blood of asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002 Monitoring of sputum eosinophils in long-term treatment of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002